相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-term Follow-up and Outcome of Phenylketonuria Patients on Sapropterin: A Retrospective Study
Stefanie Keil et al.
PEDIATRICS (2013)
Systemic and Vascular Oxidation Limits the Efficacy of Oral Tetrahydrobiopterin Treatment in Patients With Coronary Artery Disease
Colin Cunnington et al.
CIRCULATION (2012)
Bi-modal dose-dependent cardiac response to tetrahydrobiopterin in pressure-overload induced hypertrophy and heart failure
An L. Moens et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
Ratio of 5,6,7,8- tetrahydrobiopterin to 7,8- dihydrobiopterin in endothelial cells determines glucose- elicited changes in NO vs. superoxide production by eNOS (vol 294, H1530, 2008)
M. J. Crabtree et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
Relative Bioavailability of Sapropterin From Intact and Dissolved Sapropterin Dihydrochloride Tablets and the Effects of Food: A Randomized, Open-Label, Crossover Study in Healthy Adults
Donald G. Musson et al.
CLINICAL THERAPEUTICS (2010)
Tetrahydrobiopterin: pleiotropic roles in cardiovascular pathophysiology
Colin Cunnington et al.
HEART (2010)
Hepatic endothelial dysfunction and abnormal angiogenesis: New targets in the treatment of portal hypertension
Jaume Bosch et al.
JOURNAL OF HEPATOLOGY (2010)
Simvastatin Lowers Portal Pressure in Patients With Cirrhosis and Portal Hypertension: A Randomized Controlled Trial
Juan G. Abraldes et al.
GASTROENTEROLOGY (2009)
Beneficial effects of exogenous tetrahydrobiopterin on left ventricular remodeling after myocardial infarction in rats - The possible role of oxidative stress caused by uncoupled endothelial nitric oxide synthase
Tomoya Masano et al.
CIRCULATION JOURNAL (2008)
Pharmacokinetics of Sapropterin in Patients with Phenylketonuria
Francois Feillet et al.
CLINICAL PHARMACOKINETICS (2008)
Three-day tetrahydrobiopterin therapy increases in vivo hepatic NOS activity and reduces portal pressure in CCl4 cirrhotic rats
Vasilica Matei et al.
JOURNAL OF HEPATOLOGY (2008)
Tetrahydrobiopterin: a novel antihypertensive therapy
M. Porkert et al.
JOURNAL OF HUMAN HYPERTENSION (2008)
Ratio of 5,6,7,8-tetrahydrobiopterin to 7,8-dihydrobiopterin in endothelial cells determines glucose-elicited changes in NO vs. superoxide production by eNOS
Mark J. Crabtree et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Chronic treatment with tetrahydrobiopterin reverses endothelial dysfunction and oxidative stress in hypercholesterolaemia
F. Cosentino et al.
HEART (2008)
Altered plasma versus vascular biopterins in human atherosclerosis reveal relationships between endothelial nitric oxide synthase coupling, endothelial function, and inflammation
Charalambos Antoniades et al.
CIRCULATION (2007)
Mechanisms for the role of tetrahydrobiopterin in endothelial function and vascular disease
Tim S. Schmidt et al.
CLINICAL SCIENCE (2007)
Measurement of portal pressure and its role in the management of chronic liver disease
Jaime Bosch et al.
SEMINARS IN LIVER DISEASE (2006)
Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: A systematic review
Gennaro D'Amico et al.
GASTROENTEROLOGY (2006)
The eNOS cofactor tetrahydrobiopterin improves endothelial dysfunction in livers of rats with CCl4 cirrhosis
Vasilica Matei et al.
HEPATOLOGY (2006)
Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension
M Hernández-Guerra et al.
HEPATOLOGY (2006)
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
G D'Amico et al.
JOURNAL OF HEPATOLOGY (2006)
HPLC with electrochemical and fluorescence detection procedures for the diagnosis of inborn errors of biogenic amines and pterins
A Ormazabal et al.
JOURNAL OF NEUROSCIENCE METHODS (2005)
Tetrahydrobiopterin restores impaired coronary microvascular dysfunction in hypercholesterolaemia
CA Wyss et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)
Plasma tetrahydrobiopterin and its pharmacokinetic following oral administration
B Fiege et al.
MOLECULAR GENETICS AND METABOLISM (2004)
Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis
JG Abraldes et al.
HEPATOLOGY (2003)
Current management of portal hypertension
J Bosch et al.
JOURNAL OF HEPATOLOGY (2003)
Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria
AC Muntau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
The ratio between tetrahydrobiopterin and oxidized tetrahydrobiopterin analogues controls superoxide release from endothelial nitric oxide synthase:: an EPR spin trapping study
J Vásquez-Vivar et al.
BIOCHEMICAL JOURNAL (2002)
The paradox of nitric oxide in cirrhosis and portal hypertension: Too much, not enough
R Wiest et al.
HEPATOLOGY (2002)
Tetrahydrobiopterin restores endothelial function of coronary arteries in patients with hypercholesterolaemia
Y Fukuda et al.
HEART (2002)
分享论文
